Drug Designing: Open Access
Open Access

Personalized and Precision Medicine as a model of healthcare of the newest generation towards translational applications to move ahead as a Global International Team

28^th International Conference on Chemistry & Drug Designing

December 05-06, 2018 | Vancouver, Canada

Sergey Suchkov, Jeff Skolnick, Mariya Studneva, William Thilly, Noel Rose and Paul Barach

Sechenov University, Russia
Moscow Engineering Physical Institute, Russia
AI Evdokimov Moscow State Medical and Dental University, Russia
ISPM, Japan
PMC, USA
EPMA, EU
American Heart Association, USA
John Hopkins Medical Institutions and Harvard Medical School, USA
Wayne State University School of Medicine, USA
Georgia Institute of Technology, USA
MIT, USA

Posters & Accepted Abstracts: Drug Des

Abstract :

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, Personalized Medicine (PM). To achieve the implementation of PM concept into the daily practice including clini-cal cardiology, it is necessary to create a fundamentally new strategy based upon the subclinical recognition of bio-indicators (biopredictors and biomarkers) of hidden abnormalities long before the disease clinically manifests itself. Each decision-maker values the impact of their decision to use PM on their own budget and well-being, which may not necessarily be optimal for society as a whole. It would be extremely useful to integrate data harvesting from different databanks for applications such as prediction and personalization of further treatment to thus provide more tailored measures for the patients and persons-at-risk resulting in improved outcomes whilst securing the healthy state and wellness, reduced adverse events, and more cost-effective use of healthcare resources. One of the most advanced areas in cardiology is atherosclerosis, cardiovascular and coronary disorders as well as in myocardi-tis. A lack of medical guidelines has been identified by the majority of responders as the predominant barrier for adoption, indicating a need for the development of best practices and guidelines to support the implementation of PM into the daily practice of cardiologists! Implementation of Personalized Medicine requires a lot before current model �??physician-patient�?� could be gradually displaced by a new model �??medical advisorhealthy person-at-risk�?�. This is the reason for developing global scientific, clinical, social, and educational projects in the area of PM to elicit the content of The new branch.

Biography :

E-mail: ssuchkov57@gmail.com